Work

Supplementary Figure 5 from Adjuvant therapy with oncolytic adenovirus Delta-24-RGDOX after intratumoral adoptive T-cell therapy promotes antigen spread to sustain systemic antitumor immunity

Year: 2023

Type: supplementary-materials

Abstract: Expression of CD3 and CD8 on CD45+ leukocytes from B16F10-RFLuc-3 tumors. Delta-24-RGDOX was injected into the s.c. tumors on Days 8, 11 and 14. Leukocytes from the tumors were profiled through flow cytometry on Day 18. RGDOX: Delta-24-RGDOX.

DOI: 10.1158/2767-9764.22435855

Authors: Hong Jiang, Dong Ho Shin, Yanhua Yi, Xuejun Fan, Joy Gumin, Jiasen He, Andrew G. Gillard, Frederick F. Lang, Candelaria Gomez-Manzano, Juan Fueyo

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361821015

Cites:

Cited by:

Related to: 10